The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model

被引:0
|
作者
Nikas S.P. [1 ]
Grzybowska J. [1 ]
Papahatjis D.P. [2 ]
Charalambous A. [1 ]
Banijamali A.R. [1 ,3 ]
Chari R. [1 ]
Fan P. [1 ]
Kourouli T. [2 ]
Lin S. [1 ]
Nitowski A.J. [3 ]
Marciniak G. [1 ]
Guo Y. [1 ]
Li X. [1 ]
Wang C.-L.J. [4 ]
Makriyannis A. [1 ]
机构
[1] Department of Pharmaceutical Sciences, Center for Drug Discovery, University of Connecticut, Storrs, CT 06269
[2] Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 116-35
[3] Crompton Corp., Middlebury
[4] DuPont Merek Co., Wilmington
基金
美国国家卫生研究院;
关键词
CB1 cannabinoid receptors; Halogen substitution; Tetrahydrocannabinol;
D O I
10.1208/aapsj060430
中图分类号
学科分类号
摘要
The presence of halogens within the classical cannabinoid structure leads to large variations in the compounds' potencies and affinities for the CB1 receptors. To explore the structure activity relationships within this class of analogs we have used a series of halogen-substituted (-)-Δ8-tetrahydrocannabinol analogs and compared their affinities for the CB1 cannabinoid receptor. Our results indicate that halogen substitution at the end-carbon of the side chain leads to an enhancement in affinity with the bulkier halogens (Br, I) producing the largest effects. Conversely, 2-iodo substitution on the phenolic ring leads to a 2-fold reduction in affinity while iodo-substitution in the C1′-position of the side chain lowers the compound's affinity for CB1 by more than 8-fold. The pharmacophoric requirements resulting from halogen-substitution are explored using computer modeling methods. Copyright ©2003. All Rights Reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] The role of CB1 in intestinal permeability and inflammation
    Karwad, Mustafa A.
    Couch, Daniel G.
    Theophilidou, Elena
    Sarmad, Sarir
    Barrett, David A.
    Larvin, Michael
    Wright, Karen L.
    Lund, Jonathan N.
    O'Sullivan, Saoirse E.
    FASEB JOURNAL, 2017, 31 (08): : 3267 - 3277
  • [32] Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures
    Molina-Holgado, F
    Molina-Holgado, E
    Guaza, C
    Rothwell, NJ
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (06) : 829 - 836
  • [33] The role of CB1 receptors in sweet versus fat reinforcement:: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)
    Ward, SJ
    Dykstra, LA
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6): : 381 - 388
  • [34] Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptors
    Chen, Xiaohong
    Cowan, Alan
    Inan, Saadet
    Geller, Ellen B.
    Meissler, Joseph J.
    Rawls, Scott M.
    Tallarida, Ronald J.
    Tallarida, Christopher S.
    Watson, Mia N.
    Adler, Martin W.
    Eisenstein, Toby K.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (17) : 3378 - 3389
  • [35] Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
    Soderstrom, Ken
    Soliman, Eman
    Van Dross, Rukiyah
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [36] The effects of cannabinoids on contextual, conditioned fear in CB1 knockout and CD1 mice
    Mikics, Eva
    Dombi, Timea
    Barsvari, Beata
    Varga, Balazs
    Ledent, Catherine
    Freund, Tamas F.
    Haller, Jozsef
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (03): : 223 - 230
  • [37] Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle
    Bonz, A
    Laser, M
    Küllmer, S
    Kniesch, S
    Babin-Ebell, J
    Popp, V
    Ertl, G
    Wagner, JA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (04) : 657 - 664
  • [38] Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
    Ledent, C
    Valverde, O
    Cossu, C
    Petitet, F
    Aubert, LF
    Beslot, F
    Böhme, GA
    Imperato, A
    Pedrazzini, T
    Roques, BP
    Vassart, G
    Fratta, W
    Parmentier, M
    SCIENCE, 1999, 283 (5400) : 401 - 404
  • [39] Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB1 receptors
    Pacheco, Daniela da Fonseca
    Lima Romero, Thiago Roberto
    Gama Duarte, Igor Dimitri
    NEUROSCIENCE LETTERS, 2019, 699 : 140 - 144
  • [40] Hemodynamic effects of cannabinoids:: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors
    Wagner, JA
    Járai, Z
    Bátkai, S
    Kunos, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 423 (2-3) : 203 - 210